Dexmedetomidine premedication for fiberoptic intubation in patients of temporomandibular joint ankylosis: A randomized clinical trial

Kumkum Gupta, Manish Jain, Prashant K Gupta, Bhawna Rastogi, Sanjeev K Saxena, Aman Manngo, Kumkum Gupta, Manish Jain, Prashant K Gupta, Bhawna Rastogi, Sanjeev K Saxena, Aman Manngo

Abstract

Background: Fiberoptic intubation is the gold standard technique for difficult airway management in patients of temporomandibular joint. This study was aimed to evaluate the clinical efficacy and safety of dexmedetomidine as premedication with propofol infusion for fiberoptic intubation.

Methods: Consent was obtained from 46 adult patients of temporomandibular joint ankylosis, scheduled for gap arthroplasty. They were enrolled for thisdouble-blind, randomized, prospective clinical trial with two treatment groups - Group D and Group P, of 23 patients each. Group D patients had received premedication of dexmedetomidine 1 μg/kg infused over 10 min followed by sedative propofol infusion and the control Group P patients were given only propofol infusion to achieve sedation. Condition achieved at endoscopy, intubating conditions, hemodynamic changes and postoperative events were evaluated as primary outcome.

Results: The fiberoptic intubation was successful with satisfactory endoscopic and intubating condition in all patients. Dexmedetomidine premedication has provided satisfactory conditions for fiberoptic intubation and attenuated the hemodynamic response of fiberoptic intubation than the propofol group.

Conclusion: Fiberoptic intubation was found to be easier with dexmedetomidine premedication along with sedative infusion of propofol with complete amnesia of the procedure, hemodynamic stability and preservation of patent airway.

Keywords: Dexmedetomidine; fiberoptic intubation; propofol; sedation.

Conflict of interest statement

Conflict of Interest: None declared.

References

    1. Ovassapian A. Fiberoptic Endoscopy and the Difficult Airway. 2nd ed. New York: Lippincott- Raven; 1996.
    1. Gertler R, Brown HC, Mitchell DH, Silvius EN. Dexmedetomidine: A novel sedative-analgesic agent. Proc (Bayl Univ Med Cent) 2002;14:13–21.
    1. Lawrence CJ, De Lange S. Effects of a single pre-operative dexmedetomidine dose on isoflurane requirements and perioperative hemodynamic stability. Anaesthesia. 1997;52:736–44.
    1. Hall JE, Uhrich TD, Barney JA, Arain SR, Ebert TJ. Sedative, amnesic, and analgesic properties of small dose dexmedetomidine infu sions. Anesth Analg. 2000;90:699–705.
    1. Butt OF. An alternate method of Defogging mirrors before examination. The internet Journal of Otorhinolaryngology. 2006:5. DOI: 10.5580/2709.
    1. Khan ZP, Fergusan CN, Jones RM. Alpha-2 and imidazoline receptor agonists: Their pharmacology and therapeutic role. Anaesthesia. 1999;54:146–65.
    1. Kamibayashi T, Maze M. Clinical uses of alpha 2-adrenergic agonists. Anesthesiology. 2000;93:1345–9.
    1. Maroof M, Knan RM, Jain D, Ashraf M. Dexmedetomidine is a useful adjunct for awake intubation. Can J Anaesth. 2005;52:776–7.
    1. Abdelmalak B, Makary L, Hoban J, Doyle DJ. Dexmedetomidine as sole sedative for awake intubation in management of the critical airway. J Clin Anesth. 2007;19:370–3.
    1. Chu KS, Wang FY, Hsu HT, Lu IC, Wang HM, Tsai CJ. The effectiveness of dexmedetomidine infusion for sedating oral cancer patients undergoing awake fiberoptic nasal intubation. Eur J Anaesthesiol. 2010;27:36–40.
    1. Yavacaoglu B, Kaya FN, Baykara M, Bozkurt M, Korkmaz S. A comparison of esmolol and dexmedetomidine for attenuation of intraocular pressure and hemodynamic responses to laryngoscopy and tracheal intubation. Eur J Anaesthesiol. 2008;25:517–9.
    1. Knolle E, Oehmke MJ, Gustorff B, Hellwagner K, Kress HG. Target controlled infusion of propofol for fiberoptic intubation. Eur J Anaesthesiol. 2003;20:565–9.
    1. Rai MR, Parry TM, Dombrovskis A, Warner OJ. Remifentanil target-controlled infusion vs propofol target controlled infusion for conscious sedation for awake fiberoptic intubation: A double blind randomized controlled trial. Br J Anaesthesiol. 2008;100:125–30.
    1. Lallo A, Billard V, Bourgain JL. A comparison of propofol and remifentanil target- controlled infusions to facilitate fiberoptic nasotracheal intubation. Anesth Analg. 2009;108:852–7.
    1. Bergese SD, Khabiri B, Roberts WD, Howie MB, McSweeney TD, Gerhardt MA. Dexmedetomidine for conscious sedation in difficult awake fiberoptic intubation cases. J Clin Anesth. 2007;19:141–4.
    1. Avitsian R, Lin J, Lotto M, Ebrahim Z. Dexmedetomidine and awake fiberoptic intubation for possible cervical spine myelopathy: A clinical series. J Neurosurg Anesthesiol. 2005;17:97–9.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する